AU2002321743A1 - Sustained release pharmaceutical composition of a cephalosporin antibiotic - Google Patents

Sustained release pharmaceutical composition of a cephalosporin antibiotic

Info

Publication number
AU2002321743A1
AU2002321743A1 AU2002321743A AU2002321743A AU2002321743A1 AU 2002321743 A1 AU2002321743 A1 AU 2002321743A1 AU 2002321743 A AU2002321743 A AU 2002321743A AU 2002321743 A AU2002321743 A AU 2002321743A AU 2002321743 A1 AU2002321743 A1 AU 2002321743A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
sustained release
release pharmaceutical
cephalosporin antibiotic
cephalosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002321743A
Inventor
Sanjay Parbhatrao Boldhane
Kour Chand Jindal
Rajesh Suresh Kshirsagar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Health Care
Original Assignee
Orchid Health Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Health Care filed Critical Orchid Health Care
Publication of AU2002321743A1 publication Critical patent/AU2002321743A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
AU2002321743A 2002-08-19 2002-08-19 Sustained release pharmaceutical composition of a cephalosporin antibiotic Abandoned AU2002321743A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/003320 WO2004016250A1 (en) 2002-08-19 2002-08-19 Sustained release pharmaceutical composition of a cephalosporin antibiotic

Publications (1)

Publication Number Publication Date
AU2002321743A1 true AU2002321743A1 (en) 2004-03-03

Family

ID=31726509

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002321743A Abandoned AU2002321743A1 (en) 2002-08-19 2002-08-19 Sustained release pharmaceutical composition of a cephalosporin antibiotic

Country Status (2)

Country Link
AU (1) AU2002321743A1 (en)
WO (1) WO2004016250A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7722674B1 (en) 2005-08-12 2010-05-25 Innvotec Surgical Inc. Linearly expanding spine cage for enhanced spinal fusion
US8070813B2 (en) 2005-09-26 2011-12-06 Coalign Innovations, Inc. Selectively expanding spine cage, hydraulically controllable in three dimensions for vertebral body replacement
US9028550B2 (en) 2005-09-26 2015-05-12 Coalign Innovations, Inc. Selectively expanding spine cage with enhanced bone graft infusion
US7985256B2 (en) 2005-09-26 2011-07-26 Coalign Innovations, Inc. Selectively expanding spine cage, hydraulically controllable in three dimensions for enhanced spinal fusion
US8932355B2 (en) 2008-02-22 2015-01-13 Coalign Innovations, Inc. Spinal implant with expandable fixation
US8696751B2 (en) 2008-12-10 2014-04-15 Coalign Innovations, Inc. Adjustable distraction cage with linked locking mechanisms
US8992620B2 (en) 2008-12-10 2015-03-31 Coalign Innovations, Inc. Adjustable distraction cage with linked locking mechanisms
US20100145455A1 (en) 2008-12-10 2010-06-10 Innvotec Surgical, Inc. Lockable spinal implant
CN103211795B (en) * 2012-01-18 2017-07-11 北京天衡药物研究院有限公司 Cefaclor film-controlled slow-release micro pill capsule
CN103432095A (en) * 2013-09-11 2013-12-11 中国药科大学 Intra-gastric floating sustained-release preparation of cefalexin and preparation method thereof
AU2017202311B2 (en) 2016-04-07 2022-03-03 Howmedica Osteonics Corp. Expandable interbody implant
AU2017203369B2 (en) 2016-05-20 2022-04-28 Howmedica Osteonics Corp. Expandable interbody implant with lordosis correction
EP3292841B8 (en) 2016-09-12 2023-05-31 Howmedica Osteonics Corp. Interbody implant with independent control of expansion at multiple locations
AU2017251734B2 (en) 2016-10-26 2022-10-20 Howmedica Osteonics Corp. Expandable interbody implant with lateral articulation
EP3456294A1 (en) 2017-09-15 2019-03-20 Stryker European Holdings I, LLC Intervertebral body fusion device expanded with hardening material

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AU2001227030A1 (en) * 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
DE60205870T2 (en) * 2001-02-27 2006-06-29 Ranbaxy Laboratories, Ltd. ORAL PHARMACEUTICAL COMPOSITION OF CEFPODOXIM PROXETIL

Also Published As

Publication number Publication date
WO2004016250A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
EP1581236A3 (en) Sustained release of antiinfectives
AU2003291103A1 (en) Pharmaceutical composition
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU2002321743A1 (en) Sustained release pharmaceutical composition of a cephalosporin antibiotic
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AU2003250372A1 (en) Pharmaceutical composition
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2003226189A1 (en) Oral administration of epothilones
AU2003276525A1 (en) Novel amorphous hydrate of a cephalosporin antibiotic
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2003241671A1 (en) Controlled-release drug composition
AU2002950657A0 (en) Derivatives of monosaccharides for drug discovery
AU2003290394A1 (en) Extended release formulation of beta-lactam antibiotics
AU2003255874A1 (en) Sustained release pharmaceutical composition of a cephalosporin antibiotic
AU2003303367A1 (en) Compositions of benzoquinolizine carboxylic acid antibiotic drugs
AU2003281268A1 (en) Cephalosporin preparation for oral use
AUPS213802A0 (en) Disaccharides for drug discovery
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003284460A1 (en) Medicinal composition
AU2003208621A1 (en) A pharmaceutical composition
AU2003209533A1 (en) Process of manufacturing pharmaceutical composition useful for management of tuberculosis
AU2003262141A1 (en) Preperation of desloratatine
AU2003274410A1 (en) Pharmaceutical compositions of ganciclovir

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase